第三个千年之初肝细胞癌的治疗:肝移植及其替代品。

IF 1.5 4区医学 Q2 Medicine

Acta Gastro-Enterologica Belgica Pub Date : 2004-04-01

P Majno, G Mentha, E Giostra, S Terraz, L Rubbia-Brandt, Th Berney, L Buhler, Ch Toso, O Huber, L Spahr, I Morard, A Hadengue, Ch Becker, F Terrier, Ph Morel

{"title":"第三个千年之初肝细胞癌的治疗:肝移植及其替代品。","authors":"P Majno, G Mentha, E Giostra, S Terraz, L Rubbia-Brandt, Th Berney, L Buhler, Ch Toso, O Huber, L Spahr, I Morard, A Hadengue, Ch Becker, F Terrier, Ph Morel","doi":"","DOIUrl":null,"url":null,"abstract":"Hepatocellular carcinoma is one of the most frequent tumors worldwide, and its frequency is increasing. The management of hepatocellular carcinoma has changed in recent years, this because screening allows to discover tumors at an earlier stage, and because of effective treatments are available, such as liver transplantation, liver resection, percutaneous ablation and transarterial chemoembolization. Each one of these treatments has its own advantages and drawbacks, and range of application according to the stage of the tumor and of the underlying liver disease. This review summarizes the recent progress in the management of HCC and the practice in our unit.","PeriodicalId":50942,"journal":{"name":"Acta Gastro-Enterologica Belgica","volume":"67 2","pages":"206-22"},"PeriodicalIF":1.5000,"publicationDate":"2004-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Treatment of hepatocellular carcinoma at the dawn of the third millennium: liver transplantation and its alternatives.\",\"authors\":\"P Majno, G Mentha, E Giostra, S Terraz, L Rubbia-Brandt, Th Berney, L Buhler, Ch Toso, O Huber, L Spahr, I Morard, A Hadengue, Ch Becker, F Terrier, Ph Morel\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Hepatocellular carcinoma is one of the most frequent tumors worldwide, and its frequency is increasing. The management of hepatocellular carcinoma has changed in recent years, this because screening allows to discover tumors at an earlier stage, and because of effective treatments are available, such as liver transplantation, liver resection, percutaneous ablation and transarterial chemoembolization. Each one of these treatments has its own advantages and drawbacks, and range of application according to the stage of the tumor and of the underlying liver disease. This review summarizes the recent progress in the management of HCC and the practice in our unit.\",\"PeriodicalId\":50942,\"journal\":{\"name\":\"Acta Gastro-Enterologica Belgica\",\"volume\":\"67 2\",\"pages\":\"206-22\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2004-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta Gastro-Enterologica Belgica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Gastro-Enterologica Belgica","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

肝细胞癌是世界范围内最常见的肿瘤之一，其发病率呈上升趋势。近年来，肝细胞癌的治疗已经发生了变化，这是因为筛查可以在早期发现肿瘤，而且由于有效的治疗方法，如肝移植、肝切除术、经皮消融和经动脉化疗栓塞。每一种治疗方法都有自己的优点和缺点，并根据肿瘤的分期和潜在的肝脏疾病的应用范围。本文综述了近年来我单位在肝癌治疗方面的进展及实践。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

Treatment of hepatocellular carcinoma at the dawn of the third millennium: liver transplantation and its alternatives.

Hepatocellular carcinoma is one of the most frequent tumors worldwide, and its frequency is increasing. The management of hepatocellular carcinoma has changed in recent years, this because screening allows to discover tumors at an earlier stage, and because of effective treatments are available, such as liver transplantation, liver resection, percutaneous ablation and transarterial chemoembolization. Each one of these treatments has its own advantages and drawbacks, and range of application according to the stage of the tumor and of the underlying liver disease. This review summarizes the recent progress in the management of HCC and the practice in our unit.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Acta Gastro-Enterologica Belgica 医学-胃肠肝病学

CiteScore

2.80

自引率

20.00%

发文量

审稿时长

>12 weeks

期刊介绍： The Journal Acta Gastro-Enterologica Belgica principally publishes peer-reviewed original manuscripts, reviews, letters to editors, book reviews and guidelines in the field of clinical Gastroenterology and Hepatology, including digestive oncology, digestive pathology, as well as nutrition. Pure animal or in vitro work will not be considered for publication in the Journal. Translational research papers (including sections of animal or in vitro work) are considered by the Journal if they have a clear relationship to or relevance for clinical hepato-gastroenterology (screening, disease mechanisms and/or new therapies). Case reports and clinical images will be accepted if they represent an important contribution to the description, the pathogenesis or the treatment of a specific gastroenterology or liver problem. The language of the Journal is English. Papers from any country will be considered for publication. Manuscripts submitted to the Journal should not have been published previously (in English or any other language), nor should they be under consideration for publication elsewhere. Unsolicited papers are peer-reviewed before it is decided whether they should be accepted, rejected, or returned for revision. Manuscripts that do not meet the presentation criteria (as indicated below) will be returned to the authors. Papers that go too far beyond the scope of the journal will be also returned to the authors by the editorial board generally within 2 weeks. The Journal reserves the right to edit the language of papers accepted for publication for clarity and correctness, and to make formal changes to ensure compliance with AGEB’s style. Authors have the opportunity to review such changes in the proofs.